291 related articles for article (PubMed ID: 24889722)
1. The natural history of cerebellar degeneration of Niemann-Pick C mice monitored in vitro.
Marschalek N; Albert F; Meske V; Ohm TG
Neuropathol Appl Neurobiol; 2014 Dec; 40(7):933-45. PubMed ID: 24889722
[TBL] [Abstract][Full Text] [Related]
2. Geranylgeranyl pyrophosphate is crucial for neuronal survival but has no special role in Purkinje cell degeneration in Niemann Pick type C1 disease.
Marschalek N; Albert F; Afshordel S; Meske V; Eckert GP; Ohm TG
J Neurochem; 2015 Apr; 133(1):153-61. PubMed ID: 25319340
[TBL] [Abstract][Full Text] [Related]
3. Imatinib therapy blocks cerebellar apoptosis and improves neurological symptoms in a mouse model of Niemann-Pick type C disease.
Alvarez AR; Klein A; Castro J; Cancino GI; Amigo J; Mosqueira M; Vargas LM; Yévenes LF; Bronfman FC; Zanlungo S
FASEB J; 2008 Oct; 22(10):3617-27. PubMed ID: 18591368
[TBL] [Abstract][Full Text] [Related]
4. Chronic administration of an HDAC inhibitor treats both neurological and systemic Niemann-Pick type C disease in a mouse model.
Alam MS; Getz M; Haldar K
Sci Transl Med; 2016 Feb; 8(326):326ra23. PubMed ID: 26888431
[TBL] [Abstract][Full Text] [Related]
5. Patterned Purkinje cell degeneration in mouse models of Niemann-Pick type C disease.
Sarna JR; Larouche M; Marzban H; Sillitoe RV; Rancourt DE; Hawkes R
J Comp Neurol; 2003 Feb; 456(3):279-91. PubMed ID: 12528192
[TBL] [Abstract][Full Text] [Related]
6. Intracisternal cyclodextrin prevents cerebellar dysfunction and Purkinje cell death in feline Niemann-Pick type C1 disease.
Vite CH; Bagel JH; Swain GP; Prociuk M; Sikora TU; Stein VM; O'Donnell P; Ruane T; Ward S; Crooks A; Li S; Mauldin E; Stellar S; De Meulder M; Kao ML; Ory DS; Davidson C; Vanier MT; Walkley SU
Sci Transl Med; 2015 Feb; 7(276):276ra26. PubMed ID: 25717099
[TBL] [Abstract][Full Text] [Related]
7. Donepezil enhances Purkinje cell survival and alleviates motor dysfunction by inhibiting cholesterol synthesis in a murine model of Niemann Pick disease type C.
Seo Y; Shin Y; Kim HS; Kang I; Hong IS; Choi SW; Yu KR; Kang KS
J Neuropathol Exp Neurol; 2014 Mar; 73(3):234-43. PubMed ID: 24487798
[TBL] [Abstract][Full Text] [Related]
8. Decreased estradiol release from astrocytes contributes to the neurodegeneration in a mouse model of Niemann-Pick disease type C.
Chen G; Li HM; Chen YR; Gu XS; Duan S
Glia; 2007 Nov; 55(15):1509-18. PubMed ID: 17705200
[TBL] [Abstract][Full Text] [Related]
9. Intracerebroventricular Treatment with 2-Hydroxypropyl-β-Cyclodextrin Decreased Cerebellar and Hepatic Glycoprotein Nonmetastatic Melanoma Protein B (GPNMB) Expression in Niemann-Pick Disease Type C Model Mice.
Fukaura M; Ishitsuka Y; Shirakawa S; Ushihama N; Yamada Y; Kondo Y; Takeo T; Nakagata N; Motoyama K; Higashi T; Arima H; Kurauchi Y; Seki T; Katsuki H; Higaki K; Matsuo M; Irie T
Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33466390
[TBL] [Abstract][Full Text] [Related]
10. Reduced cerebellar neurodegeneration after combined therapy with cyclodextrin/allopregnanolone and miglustat in NPC1: a mouse model of Niemann-Pick type C1 disease.
Maass F; Petersen J; Hovakimyan M; Schmitt O; Witt M; Hawlitschka A; Lukas J; Rolfs A; Wree A
J Neurosci Res; 2015 Mar; 93(3):433-42. PubMed ID: 25400034
[TBL] [Abstract][Full Text] [Related]
11. LC3 Immunostaining in the Inferior Olivary Nuclei of Cats With Niemann-Pick Disease Type C1 Is Associated With Patterned Purkinje Cell Loss.
Gurda BL; Bagel JH; Fisher SJ; Schultz ML; Lieberman AP; Hand P; Vite CH; Swain GP
J Neuropathol Exp Neurol; 2018 Mar; 77(3):229-245. PubMed ID: 29346563
[TBL] [Abstract][Full Text] [Related]
12. Conditional Niemann-Pick C mice demonstrate cell autonomous Purkinje cell neurodegeneration.
Elrick MJ; Pacheco CD; Yu T; Dadgar N; Shakkottai VG; Ware C; Paulson HL; Lieberman AP
Hum Mol Genet; 2010 Mar; 19(5):837-47. PubMed ID: 20007718
[TBL] [Abstract][Full Text] [Related]
13. Genetic and pharmacological evidence implicates cathepsins in Niemann-Pick C cerebellar degeneration.
Chung C; Puthanveetil P; Ory DS; Lieberman AP
Hum Mol Genet; 2016 Apr; 25(7):1434-46. PubMed ID: 26908626
[TBL] [Abstract][Full Text] [Related]
14. Identification of Novel Pathways Associated with Patterned Cerebellar Purkinje Neuron Degeneration in Niemann-Pick Disease, Type C1.
Martin KB; Williams IM; Cluzeau CV; Cougnoux A; Dale RK; Iben JR; Cawley NX; Wassif CA; Porter FD
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31906248
[No Abstract] [Full Text] [Related]
15. Heat Shock Protein Beta-1 Modifies Anterior to Posterior Purkinje Cell Vulnerability in a Mouse Model of Niemann-Pick Type C Disease.
Chung C; Elrick MJ; Dell'Orco JM; Qin ZS; Kalyana-Sundaram S; Chinnaiyan AM; Shakkottai VG; Lieberman AP
PLoS Genet; 2016 May; 12(5):e1006042. PubMed ID: 27152617
[TBL] [Abstract][Full Text] [Related]
16. The adenosine A
Ferrante A; Pezzola A; Matteucci A; Di Biase A; Attorri L; Armida M; Martire A; Chern Y; Popoli P
Neurobiol Dis; 2018 Feb; 110():1-11. PubMed ID: 29079454
[TBL] [Abstract][Full Text] [Related]
17. Abnormal LAMP1 glycosylation may play a role in Niemann-Pick disease, type C pathology.
Cawley NX; Sojka C; Cougnoux A; Lyons AT; Nicoli ER; Wassif CA; Porter FD
PLoS One; 2020; 15(1):e0227829. PubMed ID: 31999726
[TBL] [Abstract][Full Text] [Related]
18. AAV9-NPC1 significantly ameliorates Purkinje cell death and behavioral abnormalities in mouse NPC disease.
Xie C; Gong XM; Luo J; Li BL; Song BL
J Lipid Res; 2017 Mar; 58(3):512-518. PubMed ID: 28053186
[TBL] [Abstract][Full Text] [Related]
19. A novel mouse model of a patient mucolipidosis II mutation recapitulates disease pathology.
Paton L; Bitoun E; Kenyon J; Priestman DA; Oliver PL; Edwards B; Platt FM; Davies KE
J Biol Chem; 2014 Sep; 289(39):26709-26721. PubMed ID: 25107912
[TBL] [Abstract][Full Text] [Related]
20. Niemann-Pick Disease Type C: from molecule to clinic.
Tang Y; Li H; Liu JP
Clin Exp Pharmacol Physiol; 2010 Jan; 37(1):132-40. PubMed ID: 19566836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
